IBD-specific Cognitive Behavioral Therapy: Sustainability of effect after three years
Rattachement africain : nl. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background and Aims ‘Inflammatory Bowel Disease (IBD)-specific-Cognitive-Behavioral Therapy’ (CBT) is effective in improving Quality of Life (QoL) and in decreasing anxiety and depression in IBD-patients with poor mental QoL, one month after completing CBT. Main aim was to examine the sustainability of treatment effects up to three years after treatment with CBT. Method Participants (n = 118) of a previously conducted randomized-control-study on the effects of ‘IBD-specific-CBT’ for IBD-patients were contacted for a long-term follow-up assessment on main outcomes: generic and IBD-specific-QoL (SF-36, IBDQ), anxiety and depression (HADS, CES-D) and DSM-IV disorders (SCID-I). Change over time was examined with multilevel-regression-analyses. Results Three years after finishing ‘IBD-specific-CBT’, 61 IBD-patients (response rate 52%) completed the follow-up SCID-I assessment and 52 patients (response rate 44%) completed the assessments for symptomatology. There were no differences between dropouts and participants at three year follow-up, except for a longer disease duration in dropouts. At three-year follow-up the chance of patients having a DSM-disorder significantly decreased with an estimated 48% (from 87% at baseline to 38% at follow-up). Multilevel analyses showed a significant improvement between baseline (n = 118) and follow-up measurements (n = 52) on outcomes: IBDQ-Total (Cohen’s d effect-size = .89), SF-36 Physical (d = .54), and SF-36 Mental (d = .69), HADS-A (d = -.77), HADS-D (d = -.65) and CES-D (d = -.55); all p < .01. QoL outcomes showed further improvement between completion (n = 90 for IBD-specific QoL and n = 91 for generic QoL) and follow-up measurements, with significant improvements for IBDQ-Total (d = 0.31) and SF-36 Physical (d = 0.32). Conclusions Sustainable positive effects of ‘IBD-specific-CBT’ for IBD-patients with poor mental QoL were found and the prevalence of mental conditions substantially decreased over three year follow-up.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- IBD-specific Cognitive Behavioral Therapy: Sustainability of effect after three years
- Date Crossref
- 29/08/2025
- Éditeur
- Leibniz Institute for Psychology (ZPID)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Amsterdam University Medical Centers Department of Medical Psychology pays non établi dans la noticeÉtablissement de santé
-
GGZ Noord-Holland-Noord pays non établi dans la noticeÉtablissement de santé
-
GGD Amsterdam pays non établi dans la noticeÉtablissement de santé
-
University Medical Center Groningen Department of Health Psychology pays non établi dans la noticeÉtablissement de santé
-
University of Amsterdam Centre for Urban Mental Health pays non établi dans la noticeUniversité ou école supérieure
-
GGZ NHN pays non établi dans la noticeInstitution
-
Department of Gastroenterology and Hepatology pays non établi dans la noticeInstitution
-
Amsterdam Public Health Research Institute pays non établi dans la noticeStructure de recherche
Department of Medical Psychology — Amsterdam University Medical Centers, GGZ Noord-Holland-Noord et GGD Amsterdam, avec 5 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.